Gartner® Report: Infographic - 2024 Top Technology Investments and Objectives in Life Sciences

As the industry’s leading biology focused R&D Cloud platform for data, collaboration, and insights, Benchling has been at the center of digital transformations for over 1,200 biotech and pharma companies. More powerful than legacy ELN, LIMS, and/or SDMS , Benchling’s R&D Cloud is the premier industry standard trusted by life science CIOs for modernizing how scientists work together. 

Benchling is excited to see the latest trends in digitization identified by the 2024 Gartner® Report on Top Technology Investments and Objectives in Life Sciences. It highlights:

  • The most critical outcomes for technology investments

  • Which technologies — from industry cloud platforms to generative AI — are likely to be implemented by 2026

  • Actions you can take towards digital readiness and maturation

Read the full 2024 Gartner Report to see what innovation trends life science executives are implementing today.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner, Infographic: 2024 Top Technology Investments and Objectives in Life Sciences, 27 October 2023.

Companies using Benchling

View Gartner report

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image